ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01064401
Brief Title: Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis ((DECIDE))

First Submitted : January 26, 2010
First Submitted that Met QC Criteria : February 5, 2010
First Posted : February 8, 2010 (Estimate)

Results First Submitted : May 31, 2016
Results First Submitted that Met QC Criteria : May 31, 2016
Results First Posted : July 11, 2016 (Estimate)

Certification/Extension First Submitted : August 21, 2015
Certification/Extension First Submitted that Met QC Criteria : August 21, 2015
Certification/Extension First Posted : September 4, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 31, 2016
Last Update Posted : July 11, 2016 (Estimate)